• Home
  • MedDevices AI
  • Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?

Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?

Key Highlights:

  • Levita Magnetics’ MARS® platform used in first gallbladder removal surgery featuring an autonomous AI-guided camera.
  • Surgery performed without a camera assistant; AI tracks surgeon’s tools and adjusts view in real time.
  • Marks a crucial step toward surgical automation, with potential to improve precision, workflow efficiency and reduce OR staffing needs.

Autonomous Camera Enables Solo Laparoscopic Surgery

At Clínica Las Condes in Santiago, Chile, a gallbladder removal surgery was carried out by a surgeon without a human camera operator. Instead, an autonomous, AI-powered camera tracked the surgeon’s tools and continuously adjusted its angle, maintaining optimal visualization throughout the procedure. Ricardo Funke, chief of surgery, reported that the camera “was following me wherever I moved my hands … the whole process was excellent.”

MARS Platform: Technology & Capabilities

The operation leveraged Levita’s Magnetic-Assisted Robotic Surgery (MARS) system combined with magnetic surgical instruments and software intelligence. The autonomous camera system, using a high-definition 4K camera, automatically tracked and followed instruments, reducing dependency on a camera assistant and offering a more stable visual field.

Implications for Surgical Workflow & Safety

This advance promises multiple benefits: enhancing precision in minimally invasive surgeries, reducing delays and mistakes caused by human camera movement, potentially lowering staffing needs in operating rooms, and possibly improving patient outcomes by maintaining consistent visual focus.

Towards Surgical Automation: What’s Next?

While this case is significant, it’s one of the first in real‐patient applications. Developers and regulators will need more data on safety, reliability, variability in anatomy, and adverse situations (e.g. unexpected bleeding or instrument occlusion). A broader adoption would require regulatory approvals, clinical trials, and integration into surgical training.

Releated Posts

Prosper Medical’s $16M Raise Is a Bet That AI Can Make Concierge Medicine Affordable — Not Just Convenient

Analysis of Prosper Medical’s seed round, its AI-powered care model, and what it signals about the next phase…

ByByAnuja Singh Aug 3, 2026

The FDA Just Created a Reimbursement Pathway for AI-Driven Care — Here’s Why That Matters More Than the Device, Dexcom the first participant in its TEMPO pilot.

Analysis of the FDA’s TEMPO pilot, its first AI-enabled participant, and what it signals for how algorithmic health…

ByByAnuja Singh Aug 3, 2026

Can J&J’s Newly FDA-Approved Dual-Energy Ablation Catheter Help It Reclaim Ground Lost to Boston Scientific and Medtronic in PFA?

Key Highlights A Strategic Answer to Lost PFA Ground Johnson & Johnson enters the U.S. dual-energy ablation market…

ByByAnuja Singh Jul 16, 2026

Tsinghua’s Agent Hospital Pilots: World’s First AI Hospital or Closed Data Experiment?

Tsinghua University’s “world’s first AI Hospital” advanced public pilots February 28-March 2, 2026—deploying 42 AI agents across 300+…

ByByAnuja Singh Mar 4, 2026
Scroll to Top